It would encourage people to determine why elevated levels of 17β-HSD10/SCHAD, besides Aβ and phosphorylated Tau, are present in the brains of AD and some Down’s syndrome patients with AD pathology as well as mouse AD models. Here, MAPT is linked to Alzheimer disease.